Engineering better solutions for people with heart failure
|
HemoCath
Engineering better solutions for people with heart failure
|
HemoCath is a US/Irish pre-revenue company that has developed and is now commercializing the HemoCath™ pulmonary artery (PA) catheter and the Luc™ AI platform — offering the potential to improve clinical outcomes and reduce healthcare costs for people with heart failure (HF).
|
|